Données cliniques — Decubi
Les données présentées ci-dessous sont issues d’évaluations indépendantes menées dans des environnements cliniques reconnus. Elles constituent la base scientifique sur laquelle repose le positionnement du matelas Decubi.
4 Sources cliniques de référence
1 Référentiel international (EPUAP/NPIAP/PPPIA)
Cliniques de référence
01
Réduction de 56% du taux d'escarres — évaluation multisite hybride
Source
Wounds UK, 2016
Périmètre
650 000+ admissions patients, 5 sites, 4 230 matelas
Résultats
Réduction de 56% du taux d’escarres
- jusqu'à 6 500h de temps soignant libéré sur 12 mois
- économies jusqu'à 55% vs approche dynamique traditionnelle
- Worry levels
- Results demonstrated a significant increase in:
- psychological well-being
02 & 03
CalmiGo's Efficacy in the Treatment of PTSD & Anxiety in Army Veterans - A Randomized Control Trial
Location
Reichman University & Non-Profit organization that supports veterans
Population
Veterans suffering from anxiety and PTSD
Results
Two studies showed significant decrease in both the PTSD and anxiety levels of the veterans after just two weeks of use.
04
The Effect of CalmiGo on Stress and Burnout in Healthcare Employees
Location
Sourasky Medical Center
Population
Healthcare professionals working in the Oncology Department
Description
The study demonstrates significant improvements in employees’ burnout, emotional exhaustion, depersonalization, personal accomplishment, and stress levels. This study has already been submitted for publication.
05
Effectiveness of Using CalmiGo in Oncology Patients Suffering From Anxiety
Location
Sourasky Medical Center
Population
Oncology patients suffering from anxiety & stress
Description
The study demonstrated a significant reduction in patients’ anxiety and panic levels, along with a significant increase in quality of life. The improvements were even more substantial for patients with higher anxiety levels at the beginning of the study.
06
Breathing for the Reduction of Enteric Symptoms and Anxiety - A Randomized Single Center Study in Patients with Symptoms of Gastroparesis
Location
Ohio State University, Wexner Medical Center
Population
People suffering from gastrointestinal issues
Description
Abdominal bloating is a very common and often quite debilitating complaint affecting nearly 18% of people worldwide. Results demonstrated a significant reduction in abdominal bloating
On-Going Studies
01
Using CalmiGo to Manage Anxiety and Panic Attack Symptoms in the Emergency Department
Location
Northwell Health Emergency Department
Population
Patients arriving to the ER with anxiety or panic attacks
Description
Patients with anxiety can sometimes arrive to the ER when their symptoms are severe. This study examined the impact of CalmiGo on patients with anxiety during their visit to the Emergency Department.
02
Evaluation of CalmiGo’s Effect on Speech and Voice Biomarkers in Physicians with Burnout
Location
Abbott Northwestern Hospital, Minneapolis, MN
Population
Physicians experiencing burnout.
Description
This study assesses the impact of CalmiGo use on acoustic features derived from speech and voice samples, peripheral endothelial function, and mental stress and burnout levels, compared to standard of care.